Malignant Brenner tumors of the ovary and tumor markers: Case reports

Japanese Journal of Clinical Oncology

Volumn 29, Issue 6, 1999, Pages 308-313

  Yamamoto, Ritsu ^a   Fujita, Miri ^a   Kuwabara, Michiya ^a   Sogame, Masashi ^a   Ebina, Yasuhiko ^a   Sakuragi, Noriaki ^a   Kato, Hiroshi ^b   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CA125; CA72 4; Immunohistochemistry; Malignant Brenner tumor; SCC

Indexed keywords

CA 125 ANTIGEN; CA 72 4 ANTIGEN; CA-72-4 ANTIGEN; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BLOOD; BRENNER TUMOR; CASE REPORT; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIVER TUMOR; LYMPH NODE METASTASIS; METASTASIS; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; SECOND CANCER; SPINAL CORD TUMOR; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; BRENNER TUMOR; CA-125 ANTIGEN; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; SERPINS; SPINAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033145114     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.6.308     Document Type: Article

References (10)

1. Davis HW, Zurawski VR, Bast RC. Characterization of the CA 125 antigen associated with epithelial ovarian carcinomas. Cancer Res 1986;46:6143-8.
2. Muraro R, Kuroki M, Wunderlich D, Poole DJ, Cocher D, Thor A, et al. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen. Cancer Res 1988;48:4588-96.
3. Tsuyama S, Hashimoto K, Nakamura K, Tamura H, Sasaki K, Kato H. Different behaviors in the production and release of SCC antigen in squamous-cell carcinoma. Tumor Biol 1991;12:28-34.
4. Joh K, Aizawa S, Ohkawa K, Dohzono H, Aida S, Ohgoshi E. Case report of a malignant Brenner tumor with hyperestrogenism. Pathol Int 1995;45:75-84.
5. de Lima GR, de Lima OA, Baracat EC, Vasserman J, Burnier M. Virilizing Brenner tumor of the ovary: case report. Obstet Gynecol 1989;73:895-8.
6. Rose PG, Reale FR, Longcope C, Hunter RE. Prognostic significance of estrogen and progesterone receptors in epithelial ovarian cancer. Obstet Gynecol 1990;76:258-63.
7. Harding M, Cowan S, Hole D, Cassidy L, Kitchener H, Davis J, et al. Estrogen and procesterone receptors in ovarian cancer. Cancer 1990;65:486-91.
8. von Numers C. A contribution to the case knowledge and histology of the Brenner tumor, do malignant forms of the Brenner tumor also occur? Acta Obstet Gynecol Scand 1945;2(Suppl):114-27.
9. Roth LM, Gersell DJ, Ulbright TM. Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J J Gynecol Pathol 1993;12:128-33.
10. Hull MGR, Campbell GR. The malignant Brenner tumor. Obstet Gynecol 1973;42:527-34.